Troponin and Cardiac Biomarkers

Cardiac troponin is the preferred biomarker for detecting myocardial injury and is central to the diagnosis of myocardial infarction. Measuring troponin, increasingly with high-sensitivity assays, allows the emergency clinician to identify or exclude myocyte necrosis in patients with possible acute coronary syndrome, complementing the symptom history and the electrocardiogram.

Definition

Cardiac troponins (troponin T and troponin I) are regulatory proteins released into the blood when cardiomyocytes are injured; their measurement, interpreted as a value above the 99th-percentile reference limit with a rising or falling pattern in the right clinical context, is used to detect myocardial injury and diagnose myocardial infarction.

Scope

This topic covers the role of cardiac troponin and related biomarkers in the diagnosis and risk stratification of acute coronary syndrome, the meaning of a rising-and/or-falling troponin pattern, and the implications of high-sensitivity assays for early rule-in and rule-out. It is a reference and educational entry concerned with interpretation, not with specific testing protocols or treatment thresholds for an individual patient.

Core questions

• Why is cardiac troponin the preferred biomarker for myocardial injury?
• How does a rising or falling troponin pattern distinguish acute infarction from chronic elevation?
• What do high-sensitivity assays add to the early evaluation of chest pain?
• How does troponin contribute to risk stratification in acute coronary syndrome?

Key concepts

• Cardiac troponin T and troponin I
• 99th-percentile upper reference limit
• Rising and/or falling pattern (dynamic change)
• High-sensitivity troponin assays
• Myocardial injury versus myocardial infarction
• Rapid rule-in and rule-out pathways

Mechanisms

Troponins are components of the contractile apparatus of cardiomyocytes, and when these cells are injured the proteins are released into the circulation, where they can be detected by immunoassay. Because troponin is highly specific to cardiac muscle, an elevation indicates myocardial injury, though not its cause; a dynamic rise and/or fall in serial samples, together with clinical evidence of ischaemia, distinguishes acute myocardial infarction from chronic troponin elevation due to other conditions. High-sensitivity assays detect lower concentrations and earlier changes, enabling more rapid assessment (Thygesen et al., 2018; Reichlin et al., 2009).

Clinical relevance

Troponin testing allows clinicians to detect or exclude myocardial injury and, combined with the clinical picture and electrocardiogram, to support the diagnosis of myocardial infarction and estimate risk. The interpretive principles summarised here describe how the evidence is applied, including the importance of serial sampling and assay-specific reference limits; they are educational and not a basis for individual diagnostic or treatment decisions.

Evidence & guidelines

The Fourth Universal Definition of Myocardial Infarction (Thygesen et al., 2018) establishes troponin above the 99th-percentile reference limit, with a rising or falling pattern, as the biomarker criterion for infarction. Studies of high-sensitivity assays (Reichlin et al., 2009) demonstrated earlier and more accurate diagnosis, and earlier work established troponin's prognostic value (Ohman et al., 1996). Contemporary guidelines (Byrne et al., 2023) incorporate high-sensitivity troponin into structured rule-in and rule-out pathways.

History

Cardiac biomarker testing evolved from less specific enzymes such as creatine kinase toward cardiac troponin, which proved both highly specific for myocardial injury and prognostically informative (Ohman et al., 1996). The development of high-sensitivity assays (Reichlin et al., 2009) shortened the time needed to diagnose or exclude infarction, and successive universal definitions of myocardial infarction (Thygesen et al., 2018) formalised troponin's central diagnostic role.

Seminal works

• thygesen-2018
• reichlin-2009
• ohman-1996

Frequently asked questions

Does an elevated troponin always mean a heart attack?

No. Troponin elevation indicates myocardial injury but not its cause; many non-ischaemic conditions can raise troponin, so a diagnosis of myocardial infarction requires a dynamic rise or fall together with clinical evidence of ischaemia.

What is high-sensitivity troponin?

High-sensitivity troponin refers to assays able to detect lower concentrations and smaller changes, which allows earlier detection of myocardial injury and supports faster rule-in and rule-out assessment of chest pain.